HER2/Neu Positive Recruiting Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01750073Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast CancerTreatment